Back to Search
Start Over
The risk of recurrent VTE and major bleeding in a commercially‐insured population of cancer patients treated with anticoagulation
- Source :
- American Journal of Hematology
- Publication Year :
- 2018
- Publisher :
- John Wiley & Sons, Inc., 2018.
- Subjects :
- Risk
medicine.medical_specialty
Population
Hemorrhage
030204 cardiovascular system & hematology
03 medical and health sciences
Insurance
0302 clinical medicine
Text mining
Rivaroxaban
Recurrence
Internal medicine
Neoplasms
Correspondence
Medicine
Humans
education
Aged
education.field_of_study
business.industry
E‐only Article
Cancer
Anticoagulants
Hematology
Venous Thromboembolism
Heparin, Low-Molecular-Weight
Middle Aged
medicine.disease
030220 oncology & carcinogenesis
E‐only Articles
Warfarin
business
Major bleeding
Subjects
Details
- Language :
- English
- ISSN :
- 10968652 and 03618609
- Volume :
- 94
- Issue :
- 2
- Database :
- OpenAIRE
- Journal :
- American Journal of Hematology
- Accession number :
- edsair.doi.dedup.....2d3576b5f1163cd813e237d367574def